Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shu-Fu Lin
A Cyclin-Dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer
PLoS ONE
Multidisciplinary
Long-Term Follow-Up of Papillary and Follicular Thyroid Carcinomas With Bone Metastasis
PLoS ONE
Multidisciplinary
Related publications
Preliminary Crysallization of a Cyclin-Dependent Kinase Inhibitor: P18
Acta Crystallographica Section A Foundations of Crystallography
Management of Adverse Events During Cyclin-Dependent Kinase 4/6 (CDK4/6) Inhibitor-Based Treatment in Breast Cancer
Therapeutic Advances in Medical Oncology
Oncology
The Cyclin-Dependent Kinase Inhibitor P27Kip1 Induces N-Terminal Proteolytic Cleavage of Cyclin A
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Repositioning of a Cyclin-Dependent Kinase Inhibitor GW8510 as a Ribonucleotide Reductase M2 Inhibitor to Treat Human Colorectal Cancer
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
Cyclin-Dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis
Journal of Clinical Investigation
Medicine
Modulation of Apoptosis by the Cyclin-Dependent Kinase Inhibitor P27Kip1
Journal of Clinical Investigation
Medicine
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
Cancer Research
Cancer Research
Oncology
Calcium/Calmodulin-Dependent Protein Kinase II and Its Endogenous Inhibitor in Medullary Thyroid Cancer
Clinical Cancer Research
Cancer Research
Oncology
Regulation of Protein Phosphatase Inhibitor-1 by Cyclin-Dependent Kinase 5
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology